SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Clinical trials for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS trials appear
Sign up with your email to follow new studies for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could ease arthritis in kids – major trial underway
Disease control Recruiting nowThis study tests whether baricitinib, a daily pill, is safe and works for children aged 1 to under 18 with systemic juvenile idiopathic arthritis (sJIA), a chronic inflammatory disease. About 58 children will receive either baricitinib or a standard injected drug (tocilizumab) to…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New study tracks ilaris use in rare inflammatory diseases across europe
Disease control Recruiting nowThis study looks at how patients with Familial Mediterranean Fever (FMF) and Still's disease (including systemic juvenile idiopathic arthritis and adult-onset Still's disease) use the drug canakinumab (Ilaris) over the long term. Researchers will track 160 patients across Europe …
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC